Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Analysts predict that the market for GLP-1 drugs will expand rapidly over the next decade, and several companies could capitalize on it
Mor, M
TABLE 1 Major roles of melatonin and their relevance to aging
Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk
US$ 24.85
US$ 24.01
US$ 24.77
US$ 23.42
/product/58/4956914/1.jpg?1313)
/product/04/6648952/7.jpg?4389)
US$ 23.85
US$ 25.90
US$ 25.81
